Chitwood Melanie H, Russi Marcus, Gunasekera Kenneth, Havumaki Joshua, Klaassen Fayette, Pitzer Virginia E, Salomon Joshua A, Swartwood Nicole A, Warren Joshua L, Weinberger Daniel M, Cohen Ted, Menzies Nicolas A
Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, Yale University, New Haven, Connecticut USA.
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts US.
medRxiv. 2021 Jul 22:2020.06.17.20133983. doi: 10.1101/2020.06.17.20133983.
Reported COVID-19 cases and deaths provide a delayed and incomplete picture of SARS-CoV-2 infections in the United States (US). Accurate estimates of both the timing and magnitude of infections are needed to characterize viral transmission dynamics and better understand COVID-19 disease burden. We estimated time trends in SARS-CoV-2 transmission and other COVID-19 outcomes for every county in the US, from the first reported COVID-19 case in January 13, 2020 through January 1, 2021. To do so we employed a Bayesian modeling approach that explicitly accounts for reporting delays and variation in case ascertainment, and generates daily estimates of incident SARS-CoV-2 infections on the basis of reported COVID-19 cases and deaths. The model is freely available as the R package. Nationally, we estimated there had been 49 million symptomatic COVID-19 cases and 400,718 COVID-19 deaths by the end of 2020, and that 27% of the US population had been infected. The results also demonstrate wide county-level variability in the timing and magnitude of incidence, with local epidemiological trends differing substantially from state or regional averages, leading to large differences in the estimated proportion of the population infected by the end of 2020. Our estimates of true COVID-19 related deaths are consistent with independent estimates of excess mortality, and our estimated trends in cumulative incidence of SARS-CoV-2 infection are consistent with trends in seroprevalence estimates from available antibody testing studies. Reconstructing the underlying incidence of SARS-CoV-2 infections across US counties allows for a more granular understanding of disease trends and the potential impact of epidemiological drivers.
报告的新冠病毒病(COVID-19)病例和死亡情况,只能为美国SARS-CoV-2感染情况提供滞后且不完整的信息。要描述病毒传播动态并更好地了解COVID-19疾病负担,需要准确估计感染的时间和规模。我们估计了美国各县从2020年1月13日首次报告COVID-19病例到2021年1月1日期间SARS-CoV-2传播及其他COVID-19相关结果随时间的变化趋势。为此,我们采用了一种贝叶斯建模方法,该方法明确考虑了报告延迟和病例确诊的差异,并根据报告的COVID-19病例和死亡情况生成每日SARS-CoV-2感染发病数的估计值。该模型可作为R包免费获取。在全国范围内,我们估计到2020年底有4900万例有症状的COVID-19病例和400,718例COVID-19死亡病例,并且美国27%的人口已被感染。结果还表明,发病率的时间和规模在县级层面存在很大差异,当地的流行病学趋势与州或地区平均水平有很大不同,导致到2020年底估计的感染人口比例存在很大差异。我们对与COVID-19相关的真实死亡人数的估计与超额死亡率的独立估计结果一致,并且我们对SARS-CoV-2感染累计发病率的估计趋势与现有抗体检测研究中血清流行率估计趋势一致。重建美国各县SARS-CoV-2感染的潜在发病率,有助于更细致地了解疾病趋势以及流行病学驱动因素的潜在影响。